LASA

Lasa Supergenerics Share PriceLasa Supergenerics

₹18.3
0.2 (1.1%)
As on 31 March, 2023 | 20:47 BSE: 540702 NSE: LASA

Lasa Supergenerics Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Lasa Supergenerics

Start SIP

Lasa Supergenerics Share Price

  • Over 1 Month -23.75%
  • Over 3 Month -45.62%
  • Over 6 Month -51.2%
  • Over 1 Year -56.22%

Lasa Supergenerics Key Statistics

P/E Ratio -6.6
PEG Ratio -0.4
Market Cap Cr 74
Price to Book Ratio 0.5
EPS 0.5
Dividend 1.4
Relative Strength Index 26.28
Money Flow Index 31.02
MACD Signal -1.55
Average True Range 1.69

Lasa Supergenerics Investment Rating

  • Master Rating:
  • Lasa Supergenerics has an operating revenue of Rs. 145.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -5% needs improvement, ROE of -3% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 4 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 32342951
Operating Expenses Qtr Cr 34343740
Operating Profit Qtr Cr -20-811
Depreciation Qtr Cr 3333
Interest Qtr Cr 0100
Tax Qtr Cr 001-1
Net Profit Qtr Cr -5-7-1212

Lasa Supergenerics Technicals

EMA & SMA

Current Price
₹18.3
0.2 (1.1%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 21.43
  • 50 Day
  • 24.29
  • 100 Day
  • 27.54
  • 200 Day
  • 33.15
  • 20 Day
  • 21.92
  • 50 Day
  • 24.45
  • 100 Day
  • 28.28
  • 200 Day
  • 31.8

Lasa Supergenerics Resistance and Support

PIVOT
₹17.86
Resistance
First Resistance 18.61
Second Resistance 19.11
Third Resistance 19.86
RSI 26.28
MFI 31.02
MACD Single Line -1.55
MACD -1.9
Support
First Resistance 17.36
Second Resistance 16.61
Third Resistance 16.11

Lasa Supergenerics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 239,938 17,491,480 72.9
Week 185,189 13,818,785 74.62
1 Month 96,993 6,797,252 70.08
6 Month 138,281 7,373,122 53.32

Lasa Supergenerics Result Highlights

Lasa Supergenerics Synopsis

NSE-Medical-Ethical Drugs

Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 137.13 Cr. and Equity Capital is Rs. 40.67 Cr. for the Year ended 31/03/2022. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.
Market Cap 75
Sales 145
Shares in Float 2.28
No of funds 1
Yield 1.38
Book Value 0.5
U/D Vol ratio 0.8
LTDebt / Equity
Alpha -0.18
Beta 1.19

Lasa Supergenerics

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 43.78%43.78%43.78%
Foreign Portfolio Investors 0.4%
Individual Investors 38.13%38.01%36.74%
Others 18.09%18.21%19.08%

Lasa Supergenerics Management

Name Designation
Dr. Omkar Pravin Herlekar Chairman & Managing Director
Mr. Shivanand G Hegde Whole Time Director
Mr. Hardesh Raja Tolani Independent Director
Ms. Ekta Avtar Gurnasinghani Independent Director
Mr. Ajay Hareshlal Sukhwani Independent Director
Ms. Manali Roop Bhagtani Independent Director

Lasa Supergenerics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lasa Supergenerics MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Lasa Supergenerics FAQs

What is Share Price of Lasa Supergenerics ?

Lasa Supergenerics share price is ₹18 As on 31 March, 2023 | 20:33

What is the Market Cap of Lasa Supergenerics ?

The Market Cap of Lasa Supergenerics is ₹74.4 Cr As on 31 March, 2023 | 20:33

What is the P/E ratio of Lasa Supergenerics ?

The P/E ratio of Lasa Supergenerics is -6.6 As on 31 March, 2023 | 20:33

What is the PB ratio of Lasa Supergenerics ?

The PB ratio of Lasa Supergenerics is 0.5 As on 31 March, 2023 | 20:33

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number